Challenging the current treatment paradigm for methicillin-resistant staphylococcus epidermidis peritonitis in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 22, Issue 3, 2002, Pages 335-338

  Ariano, Robert E ^a   Franczuk, Christine ^a   Fine, Adrian ^a   Harding, Godfrey K M ^a   Zelenitsky, Sheryl A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cefazolin; Methicillin resistance; Staphylococcus epidermidis peritonitis; Tobramycin; Vancomycin

Indexed keywords

CEFAZOLIN; METICILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FISHER EXACT TEST; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PENICILLIN RESISTANCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036586875     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200306     Document Type: Article

References (10)

1. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper T, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
2. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000; 36:1009-13.
3. Agraharkar M, Klevjer-Anderson P, Rubinstien E, Galen M. Use of cefazolin for peritonitis treatment in peritoneal dialysis patients. Am J Nephrol 1999; 19:555-8.
4. Vas S, Bargman J, Oreopoulos DG. Treatment of PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17:91-4.
5. Golper T. Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int 1997; 17:11-12.
6. Goldberg L, Clemenger M, Azadian B, Brown EA. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Am J Kidney Dis 2001; 37:49-55.
7. Krediet TG, Jones ME, Gerards LJ, Fleer A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999; 103:e29:1-5.
8. Collins RF, Edwards LD. In vitro synergy of cefazolintobramycin against gram-positive bacteria. J Antimicrob Chemother 1980; 6:323-31.
9. Gruer LD, Bartlett R, Ayliffe GAJ. Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother 1984; 13:577-83.
10. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update (Published erratum appears in Perit Dial Int 2000; 20:828-9). Perit Dial Int 2000; 20:396-411.